TGF-?1 and TGF-?R1 variants are associated with clinical outcomes in smoking-related head and neck cancer patients treated with chemoradiation through modulating microRNA-mediated regulation. Cancer Immunol Immunother. 2024 Mar 30; 73(5):85.